Correlation Between Dupont De and Novozymes A/S
Can any of the company-specific risk be diversified away by investing in both Dupont De and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Novozymes AS B, you can compare the effects of market volatilities on Dupont De and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Novozymes A/S.
Diversification Opportunities for Dupont De and Novozymes A/S
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Dupont and Novozymes is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of Dupont De i.e., Dupont De and Novozymes A/S go up and down completely randomly.
Pair Corralation between Dupont De and Novozymes A/S
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.73 times more return on investment than Novozymes A/S. However, Dupont De Nemours is 1.37 times less risky than Novozymes A/S. It trades about 0.03 of its potential returns per unit of risk. Novozymes AS B is currently generating about -0.1 per unit of risk. If you would invest 8,327 in Dupont De Nemours on August 31, 2024 and sell it today you would earn a total of 63.00 from holding Dupont De Nemours or generate 0.76% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dupont De Nemours vs. Novozymes AS B
Performance |
Timeline |
Dupont De Nemours |
Novozymes AS B |
Dupont De and Novozymes A/S Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dupont De and Novozymes A/S
The main advantage of trading using opposite Dupont De and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.Dupont De vs. Eastman Chemical | Dupont De vs. Air Products and | Dupont De vs. Linde plc Ordinary | Dupont De vs. Ecolab Inc |
Novozymes A/S vs. Sherwin Williams Co | Novozymes A/S vs. Air Liquide SA | Novozymes A/S vs. LAir Liquide SA | Novozymes A/S vs. Air Products and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |